Moderators: QuantumTravesty
Search This Board: 
Created: 01/25/2013 01:09:32 PM - Followers: 49 - Board type: Free - Posts Today: 0

  https://www.kintara.com/
Kintara Therapeutics is focused on developing unique anti-cancer compounds, supported by a strong scientific rationale for development in indications with established biomarkers, and where patients are failing, or are unable to tolerate, current therapies.

           VAL-083 Shows Potential Against Multiple Cancers 

VAL-083 is a "first-in-class" small molecule chemotherapeutic. Its unique structure provides many valuable benefits, including the targeting of DNA for its therapeutic effect and its ability to cross the blood brain barrier, critical for activity against central nervous system (CNS) tumors.

VAL-083 has completed Pre-Clinical, Phase I and II trials for the treatment of bevacizumab-refractory glioblastoma multiforme (GBM) and is currently being studied in two Phase II biomarker-driven clinical trials for unmethylated-MGMT GBM.

We are also pursuing the development of VAL-083 in the treatment of ovarian cancer.

 

REM-001 is a Proprietary Late Stage Photodynamic Therapy (“PDT”) Platform 

REM-001 has broad utility for the treatment of serious cutaneous oncology indications. REM-001 has been previously studied in four Phase 2 and/or Phase 3 clinical trials in patients with cutaneous metastatic breast cancer (“CMBC”), who had previously received chemotherapy and/or failed radiation therapy.

Zacks Small-Cap Research
https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_10112021_KTRA_Vandermosten.pdf
Based on our DCF model and a 15% discount rate, Kintara Therapeutics is valued at approximately $5.25 per share. Our model applies a 60% probability for VAL-083 in unmethylated GBM, a 50% probability in methylated GBM and a 50% probability of approval and commercialization in REM-001 for CMBC. The model includes contributions from the United States and Europe. Other regions will be included upon further clarity.
Shares Outstanding (mil) 43.2
Current Price (10/8/2021) $0.77
Valuation $5.25.   

11/03/21

Thanks to its promising pipeline and $0.88 share price, 5-star analyst Michael King, of
H.C. Wainwright, sees an attractive entry point for investors.

“We are bullish about KTRA shares for the following five reasons
: (1) The GBM AGILE trial tests VAL-083 in
all three subtypes of GBM, allowing for multiple opportunities for VAL-083 to prove its
efficacy against phenotypically distinct types of the disease.
(2) VAL-083 is a bifunctional
alkylating agent that crosses the blood brain barrier and exhibits very favorable pharmacologic
properties relative TMZ; fulfilling the need for systemic availability in the brain.
(3) VAL-083
has an established favorable safety record, both from initial trials and prior clinical use in
multiple indications.
(4) Dire unmet need in GBM may present relatively low bar for approval.
(5) Phase 3 ready REM-001 is an additional bonus which is not factored into our valuation
assumptions and could potentially deliver value to shareholders while providing a backstop
against downside,” King explained.

PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#1135
Did someone on this board say that kintara Maknmoney78 09/07/2022 01:54:58 PM
#1134
So far no! Only lower lows. Looks like QuantumTravesty 09/06/2022 03:58:16 PM
#1133
Are we sure this stock actually has a blackcat 09/06/2022 03:20:41 PM
#1132
rsi 30.89 @ $0.141 is either a bounce QuantumTravesty 09/06/2022 02:31:42 PM
#1131
Lol yes I think you’re right. QuantumTravesty 09/01/2022 04:38:41 PM
#1130
Whoever coined the phrase "slow train wreck" surely blackcat 09/01/2022 01:01:19 PM
#1129
Looking for a break of rsi 30 and QuantumTravesty 09/01/2022 12:16:49 PM
#1128
https://dbtnews.com/2022/08/27/why-kintara-therapeutics-inc-ktra-is-a-good-choic Maknmoney78 08/29/2022 11:41:55 AM
#1127
Anyone else loaded up more of these .15s Maknmoney78 08/24/2022 03:55:38 PM
#1126
My PCP thinks the CDC is looking at blackcat 08/18/2022 06:17:52 PM
#1125
Yeah that’s a bit of what I’ve been QuantumTravesty 08/18/2022 04:05:19 PM
#1124
We've all been planning trips "by booster shots". blackcat 08/18/2022 11:17:37 AM
#1123
Yes on all of that! All I have QuantumTravesty 08/18/2022 10:33:09 AM
#1122
Using a phone for trades can be hazardous! blackcat 08/18/2022 09:57:33 AM
#1121
That’s good. That’s what I was trying to QuantumTravesty 08/18/2022 09:44:35 AM
#1120
Haven't bought back. Just waiting................. blackcat 08/17/2022 02:33:18 PM
#1119
Well $0.18 is the new $0.20 QuantumTravesty 08/17/2022 10:58:54 AM
#1118
Par for their course............... blackcat 08/09/2022 10:44:45 AM
#1117
Who’s surprised here? QuantumTravesty 08/09/2022 10:20:13 AM
#1116
Well- I don't think it will hold- today, blackcat 08/05/2022 02:34:58 PM
#1115
So do you think it will hold here antman 08/05/2022 01:45:34 PM
#1114
Ugly! I knew they were bad, but didn't blackcat 08/04/2022 12:55:42 PM
#1113
Yes and yet it could have some pumps QuantumTravesty 08/04/2022 12:31:09 PM
#1112
We watched too many times. Toxic financing is blackcat 08/04/2022 12:11:00 PM
#1111
Yup because they’ve now hit the bottom of QuantumTravesty 08/04/2022 11:55:51 AM
#1110
They would be better off to just let blackcat 08/04/2022 11:30:44 AM
#1109
I’m going to try not to rush in QuantumTravesty 08/04/2022 10:28:28 AM
#1108
Got the 8KSpy Alert on $KTRA .....Boom........... Zardiw 08/04/2022 08:39:53 AM
#1107
That’s a negative ghost rider the pattern is QuantumTravesty 08/03/2022 02:04:46 PM
#1106
I have a hole in my head buying antman 08/03/2022 01:38:12 PM
#1105
Oh yes. I'm looking for support at .20 blackcat 08/03/2022 12:06:16 PM
#1104
Chart says they’ll try to hold support at QuantumTravesty 08/03/2022 11:26:46 AM
#1103
Good job averaging down and going to the QuantumTravesty 08/03/2022 11:23:01 AM
#1102
Sells completed at $.30. Not a big blackcat 08/03/2022 11:00:06 AM
#1101
Ding ding ding! If that’s your situation. QuantumTravesty 08/03/2022 10:37:45 AM
#1100
The usual. we issued 1,630,191 Commitment Shares QuantumTravesty 08/03/2022 10:35:03 AM
#1099
https://www.targetedonc.com/view/fda-grants-fast-track-status-to-dianhydrogalact PENNIEStoSTACKS 08/03/2022 10:25:41 AM
#1098
Well- I have been just riding it. However- blackcat 08/03/2022 10:25:02 AM
#1097
In a case where it’s significantly upside down QuantumTravesty 08/03/2022 10:19:03 AM
#1096
Totally agree, That's why my comment was "I blackcat 08/03/2022 10:05:26 AM
#1095
Funny I missed the open and $0.40 with QuantumTravesty 08/03/2022 09:46:15 AM
#1094
Whew let’s hope that were true. Let me QuantumTravesty 08/03/2022 09:40:21 AM
#1093
KTRA doubled but isn't it just fancy words swampboots 08/03/2022 09:25:12 AM
#1092
I guess this counts as an upside catalyst......... blackcat 08/03/2022 09:05:04 AM
#1091
Kintara Therapeutics Enters Into Equity Purchase Agreement for subslover 08/03/2022 08:44:20 AM
#1090
Thanks , anyone expecting some substantial changes in ADVFN_abullman 07/31/2022 11:48:20 PM
#1089
Maybe I could just pretend I don't own any......... blackcat 07/27/2022 05:13:28 PM
#1088
RSI 30 oversold is like a lunar gravitational QuantumTravesty 07/27/2022 12:37:49 PM
#1087
Lol well yes and no. After putting in QuantumTravesty 07/26/2022 12:52:37 AM
#1086
What a surprise, yes? blackcat 07/25/2022 01:12:08 PM
Post Subject